🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2220
-0.0068 (-2.97%)
At close: Nov 20, 2026

CytoDyn Company Description

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications.

The company develops leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19.

Its leronlimab completed phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer.

The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

CytoDyn Inc.
CytoDyn logo
CountryUnited States
Founded2002
IndustryBiotechnology
SectorHealthcare
Employees14
CEORobert Hoffman

Contact Details

Address:
1111 Main Street
Vancouver, Washington 98660
United States
Phone360 980 8524
Websitecytodyn.com

Stock Details

Ticker SymbolCYDY
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJune - May
Reporting CurrencyUSD
ISIN NumberUS23283M1018
SIC Code2836

Key Executives

NamePosition
Robert E. Hoffman B.B.A., C.P.A.Chief Executive Officer and Principal Accounting Officer
Tyler BlokChief Legal Officer and Corporate Secretary
Dr. Jacob P. Lalezari M.D.Head of Research and Translational Sciences